News

More Than One-Third of Medicaid Members Say Their Health Plan Didn’t Reach Out About Renewing Coverage to Maintain Benefits

Harris Poll/Icario Survey Also Finds That 55% of Members 65-Plus Said Their Plan Hasn't Reached Out to ThemMINNEAPOLIS, July 31,…

1 year ago

Privia Health Announces Changes to Board of Directors

Distinguished Healthcare Leader Dave Wichmann and Seasoned CHRO Pam Kimmet to Join BoardARLINGTON, Va., July 31, 2023 (GLOBE NEWSWIRE) --…

1 year ago

Route 92 Medical Announces Publication of a Retrospective Study in the Interventional Neuroradiology Journal

Study shows FreeClimb 70 Reperfusion System, powered by the Tenzing 7 delivery catheter, enables neurointerventionalists to address critical unmet needs…

1 year ago

ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177

Garching / Munich, Germany and Indianapolis, IN, USA, July 31, 2023 –  ITM Isotope Technologies Munich SE (ITM), a leading…

1 year ago

ITM and POINT Biopharma Expand Global Supply Agreement for n.c.a. Lutetium-177

GARCHING / MUNICH, Germany and INDIANAPOLIS, July 31, 2023 (GLOBE NEWSWIRE) -- ITM Isotope Technologies Munich SE (ITM), a leading…

1 year ago

Blue Water Biotech and Knipper Health Join Forces to Distribute Samples for ENTADFI® and ZONTIVITY® to Physicians

CINCINNATI, July 31, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a biotechnology…

1 year ago

TRxADE HEALTH, Inc. Announces Closing of Acquisition of Superlatus, Inc.

NEW YORK, July 31, 2023 (GLOBE NEWSWIRE) -- TRxADE HEALTH, Inc. (NASDAQ: MEDS) (“TRxADE”), a pharmaceutical exchange platform provider, today…

1 year ago

COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

LONDON, July 31, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access…

1 year ago

New Publication Highlights Real World Impact of Trilaciclib on Myelosuppressive Events in Patients with Extensive Stage Small Cell Lung Cancer (ES-SCLC)

- Results Confirm that Trilaciclib Reduces Single and Multilineage Grade ≥3 Myelosuppressive Hematologic Adverse Events (HAEs) Including Neutropenia, Anemia, and…

1 year ago

Mustang Bio Announces Amendment and Closing of Strategic Manufacturing Partnership Transaction with uBriGene (Boston) Biosciences

Transaction and reduction in operating expenses enhance Mustang’s cash positionWORCESTER, Mass., July 31, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc.…

1 year ago